Source: Annual Congress 2012 - PG9 Progress on the treatment of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Buhl (Mainz, Germany). Improving COPD management through maximising bronchodilation. Annual Congress 2012 - PG9 Progress on the treatment of COPD

Member's Comments

No comment yet.

Related content which might interest you: Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 The utility of remote cough monitoring in COPD Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Real-life effectiveness of budesonide/formoterol for the management of asthma and COPD Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 Efficacy of comprehensive education program including inhaler training and disease management on COPD Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Promoting effective self-management programmes to improve COPD Source: Eur Respir J 2009; 33: 461-463 Year: 2009 Dual bronchodilation with once-daily QVA149 improves lung function and reduces exacerbations in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Predictors of good inhaler technique in asthma and COPD Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Tiotropium reduces health resource utilization associated with COPD exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 513s Year: 2004 Benefits of self-management education in COPD exacerbations Source: International Congress 2015 – Best abstracts in chronic care Year: 2015 Reproducibility of inhaler use and pulmonary drug deposition in COPD Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Once-daily QVA149 provides clinically meaningful improvements in lung function and clinical outcomes Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Measuring bronchodilation in COPD clinical trials Source: Eur Respir J 2004; 24: Suppl. 48, 122s Year: 2004 Effects of ciclesonide on the management of stable COPD with airway eosinophilia Source: Annual Congress 2013 –COPD treatment and others Year: 2013 The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Safety and efficacy of sputum induction in COPD patients Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education Year: 2013 Medication cost and efficient resource utilisation in bronchial asthma management Source: Eur Respir J 2005; 26: Suppl. 49, 274s Year: 2005 Technological aspects of inhalers in asthma and COPD management Source: CME Online 2011 Year: 2005 On improving quality of life in moderate-severe stable COPD Egyptian patients by a domiciliary pulmonary rehabilitation program Source: Eur Respir J 2004; 24: Suppl. 48, 518s Year: 2004 Effectiveness of a comprehensive management program of fragile COPD patients Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014